A Novel Bioresorbable Polymer Paclitaxel-Eluting Stent for the Treatment of Single and Multivessel Coronary Disease
Authors:
- Mitchell W. KrucoffMitchell W. Krucoff
- Dean J. KereiakesDKDean J. Kereiakes
- John L. PetersenJPJohn L. Petersen
- Roxana MehranRMRoxana Mehran
- Vic HasselbladVHVic Hasselblad
- Alexandra J. LanskyALAlexandra J. Lansky
- Peter J. FitzgeraldPFPeter J. Fitzgerald
- Jyotsna GargJGJyotsna Garg
- Mark A. TurcoMTMark A. Turco
- Charles A. SimontonCSCharles A. Simonton
- Stefan VerheyeSVStefan Verheye
- Christophe L. DuboisCDChristophe L. Dubois
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Drug-Eluting Stents “Deliver Heartburn”Circulation, 2007
- The Cobalt chromium STent with Antiproliferative for Restenosis II (COSTAR II) Trial study design: Advancing the active-control evaluation of second-generation drug-eluting stentsAmerican Heart Journal, 2007
- Thrombosis in Coronary Drug-Eluting StentsCirculation, 2007
- Clinical End Points in Coronary Stent TrialsCirculation, 2007
- Clinical Efficacy of Polymer-Based Paclitaxel-Eluting Stents in the Treatment of Complex, Long Coronary Artery Lesions From a Multicenter, Randomized TrialCirculation, 2005
- The Effect of Variable Dose and Release Kinetics on Neointimal Hyperplasia Using a Novel Paclitaxel-Eluting Stent PlatformJACC, 2005
- Surrogates, substudies, and real clinical end points in trials of drug-eluting stents**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.JACC, 2005
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- 7-Hexanoyltaxol–Eluting Stent for Prevention of Neointimal GrowthCirculation, 2002
- Statistical Methods for Comparison to Placebo in Active-Control TrialsDrug Information Journal, 2001